Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Myocarditis III: Medical Management

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...

Immune Response Against Viral Pathogens

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...

Epilepsy and Seizures: Overview

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Adjunct dexamethasone in herpes simplex virus encephalitis - Authors' reply.

The Lancet. Neurology·2026

Same author

Inter-attack serum GFAP and NfL remain stable over 9 years in AQP4 IgG NMOSD.

Journal of neurology, neurosurgery, and psychiatry·2026

Same author

Psychiatric and behavioural sequelae following encephalitis: a systematic review and meta-analysis.

Brain communications·2026

Same author

Suspected encephalitis in adults.

Practical neurology·2026

Same author

Understanding the long-term neurological effects of SARS-CoV-2 infection.

Nature reviews. Neurology·2026

Same author

Brain in FLAMES: A call for early recognition this World Encephalitis Day.

Journal of the neurological sciences·2026

Search research articles

Related Experiment Video

Updated: Sep 19, 2025

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

Viral encephalitis - update on pathogenesis and treatment.

Rachael Matthews^1,2, Brendan F Sargent^1,3, Steven McKeever¹

¹Brain Infection and Inflammation Group, Clinical Infection Microbiology and Immunology, Institute of Infection Veterinary and Ecological Sciences, University of Liverpool, Liverpool.

Current Opinion in Neurology

|June 4, 2025

Summary

This review covers new developments in viral encephalitis, including epidemiology, pathogenesis, and treatment. Simple interventions and preventive measures like vaccination are key for managing this serious brain inflammation.

Keywords:

epidemiology interventions pathophysiology preventive management viral encephalitis

More Related Videos

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease

Published on: April 28, 2019

A Model for Epilepsy of Infectious Etiology using Theiler's Murine Encephalomyelitis Virus

A Model for Epilepsy of Infectious Etiology using Theiler's Murine Encephalomyelitis Virus

Published on: June 23, 2022

Related Experiment Videos

Last Updated: Sep 19, 2025

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease

Published on: April 28, 2019

A Model for Epilepsy of Infectious Etiology using Theiler's Murine Encephalomyelitis Virus

A Model for Epilepsy of Infectious Etiology using Theiler's Murine Encephalomyelitis Virus

Published on: June 23, 2022

Area of Science:

Neurology
Infectious Diseases
Immunology

Background:

Viral encephalitis is a severe brain inflammation causing fever, altered mentation, and neurological deficits.
Understanding its epidemiology, pathogenesis, and treatment is crucial for patient outcomes.

Purpose of the Study:

To review recent advancements in the understanding of viral encephalitis.
To explore new developments in epidemiology, pathogenesis, and treatment options.

Main Methods:

Literature review of current research on viral encephalitis.
Analysis of WHO technical briefs and clinical trial data.

Main Results:

The WHO technical brief provides a framework for viral encephalitis surveillance, prevention, and management.
Adjunctive dexamethasone in herpes simplex virus encephalitis shows no significant improvement in outcomes.
Simple interventions can improve diagnosis rates in resource-limited settings.

Conclusions:

Ongoing research into pathophysiological mechanisms may lead to targeted immunotherapies.
Large-scale trials are needed to validate new treatment strategies.
Preventive measures, including surveillance, vector control, and vaccination, are vital for saving lives.